Prolonged agammaglobulinemia despite unaltered B-cell lymphopoiesis after peritransplant-rituximab administration in a child

Transplantation. 2008 Nov 15;86(9):1322-3. doi: 10.1097/TP.0b013e318188ac0c.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Agammaglobulinemia / diagnosis*
  • Agammaglobulinemia / immunology
  • Agammaglobulinemia / metabolism
  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal, Murine-Derived
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunoglobulin A / metabolism
  • Immunoglobulin G / metabolism
  • Immunoglobulin M / metabolism
  • Immunologic Factors / pharmacology*
  • Infant
  • Leukemia, Myelomonocytic, Juvenile / surgery
  • Lymphopoiesis / drug effects
  • Lymphopoiesis / immunology*
  • Male
  • Rituximab
  • Transplantation Conditioning

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulin A
  • Immunoglobulin G
  • Immunoglobulin M
  • Immunologic Factors
  • Rituximab